OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 162 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 1.86 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $4,261,000 | +1744.6% | 45,313 | -88.9% | 0.18% | +2137.5% |
| Q1 2016 | $231,000 | -73.1% | 410,071 | -18.0% | 0.01% | -70.4% |
| Q4 2015 | $860,000 | -32.1% | 500,000 | -16.7% | 0.03% | -3.6% |
| Q3 2015 | $1,266,000 | -63.5% | 600,000 | -14.3% | 0.03% | -59.4% |
| Q2 2015 | $3,465,000 | -36.8% | 700,000 | 0.0% | 0.07% | -38.4% |
| Q1 2015 | $5,481,000 | +29.2% | 700,000 | 0.0% | 0.11% | +27.3% |
| Q4 2014 | $4,243,000 | +42.4% | 700,000 | 0.0% | 0.09% | +29.4% |
| Q3 2014 | $2,980,000 | -31.1% | 700,000 | 0.0% | 0.07% | -29.9% |
| Q2 2014 | $4,326,000 | -4.9% | 700,000 | 0.0% | 0.10% | -2.0% |
| Q1 2014 | $4,550,000 | +15.4% | 700,000 | 0.0% | 0.10% | +13.8% |
| Q4 2013 | $3,943,000 | -8.1% | 700,000 | 0.0% | 0.09% | -16.3% |
| Q3 2013 | $4,290,000 | +4.8% | 700,000 | 0.0% | 0.10% | -1.9% |
| Q2 2013 | $4,094,000 | – | 700,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 5,427,559 | $2,334,000 | 1.60% |
| Scale Management, LLC | 1,312,575 | $564,000 | 1.34% |
| Foresite Capital Management III, LLC | 2,542,575 | $1,093,000 | 0.75% |
| BVF INC/IL | 5,252,100 | $2,258,000 | 0.48% |
| TIVERTON ASSET MANAGEMENT LLC | 45,313 | $4,261,000 | 0.18% |
| Baupost Group | 22,268,399 | $9,575,000 | 0.13% |
| Rhenman & Partners Asset Management AB | 1,200,000 | $516,000 | 0.09% |
| NEA Management Company, LLC | 370,900 | $1,595,000 | 0.08% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $2,649,000 | 0.06% |
| Palo Alto Investors LP | 1,673,024 | $719,000 | 0.05% |